77 related articles for article (PubMed ID: 19692829)
1. Lung mass appearing as a dilated left ventricle on Tc-99m tetrofosmin myocardial perfusion scintigraphy.
Gnanasegaran G; Williams R; Mclean E; O' Connell R; Nunan TO; O'Doherty MJ
Clin Nucl Med; 2009 Sep; 34(9):620-1. PubMed ID: 19692829
[TBL] [Abstract][Full Text] [Related]
2. Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography.
Gratz S; Kempke B; Kaiser W; Behr TM; Pfestroff A; Höffken H
Nucl Med Commun; 2008 Nov; 29(11):963-9. PubMed ID: 18836374
[TBL] [Abstract][Full Text] [Related]
3. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
5. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
6. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
Schillaci O; Monteleone F; D'Andrea N; Picardi V; Cangemi R; Cangemi V; Scopinaro F
Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
9. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of chemotherapy response in patients with small cell lung cancer using Technetium-99m-tetrofosmin.
Kao CH; Ho YJ; Shen YY; Lee JK
Anticancer Res; 1999; 19(3B):2311-5. PubMed ID: 10472350
[TBL] [Abstract][Full Text] [Related]
12. Incidental pathologic extracardiac uptake of 99mTc-tetrofosmin in myocardial perfusion imaging.
Kotsalou I; Georgoulias P; Fourlis S; Zoumboulidis A; Giaslakiotis K; Androulaki A; Chronopoulos P; Dimakopoulos N
Hell J Nucl Med; 2008; 11(1):43-5. PubMed ID: 18392227
[TBL] [Abstract][Full Text] [Related]
13. Reverse redistribution of Tc-99m tetrofosmin in a patient with "takotsubo" cardiomyopathy.
Hadase M; Kawasaki T; Asada S; Kamitani T; Kawasaki S; Sugihara H
Clin Nucl Med; 2003 Sep; 28(9):757-9. PubMed ID: 12972999
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
[TBL] [Abstract][Full Text] [Related]
15. Single-shot cardiorenal scintigraphy with 99mTc-tetrofosmin: a dynamic characterization at rest and during adenosine infusion.
Fommei E; Bruselli L; Ripoli A; Gimelli A; Ghione S; Giorgetti A; Kush A; Tagliavia ID; Passino C; Marzullo P
J Nucl Med; 2009 Aug; 50(8):1288-95. PubMed ID: 19617333
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
17. Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI.
Giorgetti A; Pingitore A; Favilli B; Kusch A; Lombardi M; Marzullo P
J Nucl Med; 2005 Aug; 46(8):1285-93. PubMed ID: 16085584
[TBL] [Abstract][Full Text] [Related]
18. Increased tc-99m tetrofosmin uptake in a mediastinal tumor during myocardial perfusion imaging.
Vijayakumar V; Soloff E; Rahman AM
Clin Nucl Med; 2004 Jun; 29(6):390-1. PubMed ID: 15166893
[No Abstract] [Full Text] [Related]
19. Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer.
Klain M; Maurea S; Lastoria S; Cuocolo A; Colao A; Lombardi G; Salvatore M
J Nucl Med; 1995 Dec; 36(12):2248-51. PubMed ID: 8523115
[TBL] [Abstract][Full Text] [Related]
20. Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: comparison with 99mTc-tetrofosmin.
Madar I; Ravert H; Dipaula A; Du Y; Dannals RF; Becker L
J Nucl Med; 2007 Jun; 48(6):1021-30. PubMed ID: 17504876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
